Alkeon Capital Management LLC 4 D Molecular Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.56 - $32.94 $11.8 Million - $19.8 Million	-602,225 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.73 - $36.04 $2.26 Million - $3.58 Million	99,299 Added 19.74%	602,225 $16.2 Million
Q2 2021 Aug 16, 2021	BUY	$22.2 - $42.29 $2.22 Million - $4.23 Million	100,000 Added 24.82%	502,926 $12.1 Million
Q1 2021 May 17, 2021	BUY	$35.94 - $52.67 $37,413 - $54,829	1,041 Added 0.26%	402,926 $17.5 Million
Q4 2020 Feb 16, 2021	BUY	$38.43 - $47.36 $15.4 Million - $19 Million	401,885 New	401,885 $16.7 Million

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $666M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.